Clinical Trial Update: Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children [Phase 4]

View source ↗

Summary

Phase 4 trial update on low-dose versus high-dose IV cyclophosphamide for proliferative lupus nephritis in children; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Mahidol University | Conditions: Renal Insufficiency, Infection | Phase 4 | Status: TERMINATED